Therapeutic drug monitoring of telaprevir in chronic hepatitis C patients receiving telaprevir-based triple therapy is useful for predicting virological response
Norihiro Furusyo*, Eiichi Ogawa, Masayuki Murata, Kazuhiro Toyoda, Hachiro Ohnishi, Kunimitsu Eiraku, Motohiro Shimizu, Yuji Harada, Fujiko Mitsumoto, Koji Takayama, Mosaburo Kainuma, Kyoko Okada, Jun Hayashi
*この論文の責任著者
研究成果: ジャーナルへの寄稿 › 学術論文 › 査読
16
被引用数
(Scopus)